SCHEMBL7799897

SCHEMBL7799897

CN(C)C(=O)CCc1c(-c2ccc(Cl)cc2)[nH]c2ccc(Cl)cc12

nearest known ligand 0.76

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSPO P30536 1/20 0.64
KDM4E B2RXH2 1/20 0.59
ALDH1A1 P00352 1/20 0.59
CYP1A2 P05177 1/20 0.59
CYP3A4 P08684 1/20 0.59
HPGD P15428 1/20 0.59
CYP2C19 P33261 1/20 0.59
SMN1; SMN2 Q16637 1/20 0.59
HSD17B10 Q99714 1/20 0.59
TACR1 P25103 2/20 0.53
PDE10A Q9Y233 1/20 0.50
APOL1 O14791 1/20 0.49
DRD2 P14416 1/20 0.49
HTR2A P28223 1/20 0.49
HTR2C P28335 1/20 0.49
EGFR P00533 1/20 0.48
SRC P12931 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6926951 0.85 TSPO (0.59) TSPOKDM4EALDH1A1CYP1A2CYP3A4
SCHEMBL7234870 0.83 TSPO (0.61) TSPOKDM4EALDH1A1CYP1A2CYP3A4
SCHEMBL24907068 0.83 APOL1 (0.68) TACR1APOL1DRD2HTR2AHTR2C
SCHEMBL7238028 0.81 TSPO (0.58) TSPOKDM4EALDH1A1CYP1A2CYP3A4
SCHEMBL6928285 0.80 TACR1 (0.55) TSPOCYP1A2HPGDCYP2C19TACR1
SCHEMBL7233621 0.80 TSPO (0.57) TSPOKDM4EALDH1A1CYP1A2CYP3A4
SCHEMBL7233607 0.79 TSPO (0.59) TSPOKDM4EALDH1A1CYP1A2CYP3A4
SCHEMBL27587301 0.79 TSPO (0.64) TSPOKDM4EALDH1A1CYP1A2CYP3A4
SCHEMBL7238513 0.79 TSPO (0.56) TSPOKDM4EALDH1A1CYP1A2CYP3A4
SCHEMBL6922317 0.79 PPARG (0.66) TSPOKDM4EALDH1A1TACR1PDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010039286-A1 2-aryl indole derivatives and their use as therapeutic agents DINNELL KEVIN (GB) 2001-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010039286-A1 2-aryl indole derivatives and their use as therapeutic agents IDO1, IDO2, CNR2 TSPO 2379/4885KDM4E 2526/4885ALDH1A1 410/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.